Cargando…
Evaluating dengue burden in Africa in passive fever surveillance and seroprevalence studies: protocol of field studies of the Dengue Vaccine Initiative
INTRODUCTION: Dengue is an important and well-documented public health problem in the Asia-Pacific and Latin American regions. However, in Africa, information on disease burden is limited to case reports and reports of sporadic outbreaks, thus hindering the implementation of public health actions fo...
Autores principales: | , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5780679/ https://www.ncbi.nlm.nih.gov/pubmed/29358421 http://dx.doi.org/10.1136/bmjopen-2017-017673 |
_version_ | 1783294784516915200 |
---|---|
author | Lim, Jacqueline Kyungah Carabali, Mabel Lee, Jung-Seok Lee, Kang-Sung Namkung, Suk Lim, Sl-Ki Ridde, Valéry Fernandes, Jose Lell, Bertrand Matendechero, Sultani Hadley Esen, Meral Andia, Esther Oyembo, Noah Barro, Ahmed Bonnet, Emmanuel Njenga, Sammy M Agnandji, Selidji Todagbe Yaro, Seydou Alexander, Neal Yoon, In-Kyu |
author_facet | Lim, Jacqueline Kyungah Carabali, Mabel Lee, Jung-Seok Lee, Kang-Sung Namkung, Suk Lim, Sl-Ki Ridde, Valéry Fernandes, Jose Lell, Bertrand Matendechero, Sultani Hadley Esen, Meral Andia, Esther Oyembo, Noah Barro, Ahmed Bonnet, Emmanuel Njenga, Sammy M Agnandji, Selidji Todagbe Yaro, Seydou Alexander, Neal Yoon, In-Kyu |
author_sort | Lim, Jacqueline Kyungah |
collection | PubMed |
description | INTRODUCTION: Dengue is an important and well-documented public health problem in the Asia-Pacific and Latin American regions. However, in Africa, information on disease burden is limited to case reports and reports of sporadic outbreaks, thus hindering the implementation of public health actions for disease control. To gather evidence on the undocumented burden of dengue in Africa, epidemiological studies with standardised methods were launched in three locations in Africa. METHODS AND ANALYSIS: In 2014–2017, the Dengue Vaccine Initiative initiated field studies at three sites in Ouagadougou, Burkina Faso; Lambaréné, Gabon and Mombasa, Kenya to obtain comparable incidence data on dengue and assess its burden through standardised hospital-based surveillance and community-based serological methods. Multidisciplinary measurements of the burden of dengue were obtained through field studies that included passive facility-based fever surveillance, cost-of-illness surveys, serological surveys and healthcare utilisation surveys. All three sites conducted case detection using standardised procedures with uniform laboratory assays to diagnose dengue. Healthcare utilisation surveys were conducted to adjust population denominators in incidence calculations for differing healthcare seeking patterns. The fever surveillance data will allow calculation of age-specific incidence rates and comparison of symptomatic presentation between patients with dengue and non-dengue using multivariable logistic regression. Serological surveys assessed changes in immune status of cohorts of approximately 3000 randomly selected residents at each site at 6-month intervals. The age-stratified serosurvey data will allow calculation of seroprevalence and force of infection of dengue. Cost-of-illness evaluations were conducted among patients with acute dengue by Rapid Diagnostic Test. ETHICS AND DISSEMINATION: By standardising methods to evaluate dengue burden across several sites in Africa, these studies will generate evidence for dengue burden in Africa and data will be disseminated as publication in peer-review journals in 2018. |
format | Online Article Text |
id | pubmed-5780679 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | BMJ Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-57806792018-01-31 Evaluating dengue burden in Africa in passive fever surveillance and seroprevalence studies: protocol of field studies of the Dengue Vaccine Initiative Lim, Jacqueline Kyungah Carabali, Mabel Lee, Jung-Seok Lee, Kang-Sung Namkung, Suk Lim, Sl-Ki Ridde, Valéry Fernandes, Jose Lell, Bertrand Matendechero, Sultani Hadley Esen, Meral Andia, Esther Oyembo, Noah Barro, Ahmed Bonnet, Emmanuel Njenga, Sammy M Agnandji, Selidji Todagbe Yaro, Seydou Alexander, Neal Yoon, In-Kyu BMJ Open Infectious Diseases INTRODUCTION: Dengue is an important and well-documented public health problem in the Asia-Pacific and Latin American regions. However, in Africa, information on disease burden is limited to case reports and reports of sporadic outbreaks, thus hindering the implementation of public health actions for disease control. To gather evidence on the undocumented burden of dengue in Africa, epidemiological studies with standardised methods were launched in three locations in Africa. METHODS AND ANALYSIS: In 2014–2017, the Dengue Vaccine Initiative initiated field studies at three sites in Ouagadougou, Burkina Faso; Lambaréné, Gabon and Mombasa, Kenya to obtain comparable incidence data on dengue and assess its burden through standardised hospital-based surveillance and community-based serological methods. Multidisciplinary measurements of the burden of dengue were obtained through field studies that included passive facility-based fever surveillance, cost-of-illness surveys, serological surveys and healthcare utilisation surveys. All three sites conducted case detection using standardised procedures with uniform laboratory assays to diagnose dengue. Healthcare utilisation surveys were conducted to adjust population denominators in incidence calculations for differing healthcare seeking patterns. The fever surveillance data will allow calculation of age-specific incidence rates and comparison of symptomatic presentation between patients with dengue and non-dengue using multivariable logistic regression. Serological surveys assessed changes in immune status of cohorts of approximately 3000 randomly selected residents at each site at 6-month intervals. The age-stratified serosurvey data will allow calculation of seroprevalence and force of infection of dengue. Cost-of-illness evaluations were conducted among patients with acute dengue by Rapid Diagnostic Test. ETHICS AND DISSEMINATION: By standardising methods to evaluate dengue burden across several sites in Africa, these studies will generate evidence for dengue burden in Africa and data will be disseminated as publication in peer-review journals in 2018. BMJ Publishing Group 2018-01-21 /pmc/articles/PMC5780679/ /pubmed/29358421 http://dx.doi.org/10.1136/bmjopen-2017-017673 Text en © Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2018. All rights reserved. No commercial use is permitted unless otherwise expressly granted. This is an Open Access article distributed in accordance with the terms of the Creative Commons Attribution (CC BY 4.0) license, which permits others to distribute, remix, adapt and build upon this work, for commercial use, provided the original work is properly cited. See: http://creativecommons.org/licenses/by/4.0/ |
spellingShingle | Infectious Diseases Lim, Jacqueline Kyungah Carabali, Mabel Lee, Jung-Seok Lee, Kang-Sung Namkung, Suk Lim, Sl-Ki Ridde, Valéry Fernandes, Jose Lell, Bertrand Matendechero, Sultani Hadley Esen, Meral Andia, Esther Oyembo, Noah Barro, Ahmed Bonnet, Emmanuel Njenga, Sammy M Agnandji, Selidji Todagbe Yaro, Seydou Alexander, Neal Yoon, In-Kyu Evaluating dengue burden in Africa in passive fever surveillance and seroprevalence studies: protocol of field studies of the Dengue Vaccine Initiative |
title | Evaluating dengue burden in Africa in passive fever surveillance and seroprevalence studies: protocol of field studies of the Dengue Vaccine Initiative |
title_full | Evaluating dengue burden in Africa in passive fever surveillance and seroprevalence studies: protocol of field studies of the Dengue Vaccine Initiative |
title_fullStr | Evaluating dengue burden in Africa in passive fever surveillance and seroprevalence studies: protocol of field studies of the Dengue Vaccine Initiative |
title_full_unstemmed | Evaluating dengue burden in Africa in passive fever surveillance and seroprevalence studies: protocol of field studies of the Dengue Vaccine Initiative |
title_short | Evaluating dengue burden in Africa in passive fever surveillance and seroprevalence studies: protocol of field studies of the Dengue Vaccine Initiative |
title_sort | evaluating dengue burden in africa in passive fever surveillance and seroprevalence studies: protocol of field studies of the dengue vaccine initiative |
topic | Infectious Diseases |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5780679/ https://www.ncbi.nlm.nih.gov/pubmed/29358421 http://dx.doi.org/10.1136/bmjopen-2017-017673 |
work_keys_str_mv | AT limjacquelinekyungah evaluatingdengueburdeninafricainpassivefeversurveillanceandseroprevalencestudiesprotocoloffieldstudiesofthedenguevaccineinitiative AT carabalimabel evaluatingdengueburdeninafricainpassivefeversurveillanceandseroprevalencestudiesprotocoloffieldstudiesofthedenguevaccineinitiative AT leejungseok evaluatingdengueburdeninafricainpassivefeversurveillanceandseroprevalencestudiesprotocoloffieldstudiesofthedenguevaccineinitiative AT leekangsung evaluatingdengueburdeninafricainpassivefeversurveillanceandseroprevalencestudiesprotocoloffieldstudiesofthedenguevaccineinitiative AT namkungsuk evaluatingdengueburdeninafricainpassivefeversurveillanceandseroprevalencestudiesprotocoloffieldstudiesofthedenguevaccineinitiative AT limslki evaluatingdengueburdeninafricainpassivefeversurveillanceandseroprevalencestudiesprotocoloffieldstudiesofthedenguevaccineinitiative AT riddevalery evaluatingdengueburdeninafricainpassivefeversurveillanceandseroprevalencestudiesprotocoloffieldstudiesofthedenguevaccineinitiative AT fernandesjose evaluatingdengueburdeninafricainpassivefeversurveillanceandseroprevalencestudiesprotocoloffieldstudiesofthedenguevaccineinitiative AT lellbertrand evaluatingdengueburdeninafricainpassivefeversurveillanceandseroprevalencestudiesprotocoloffieldstudiesofthedenguevaccineinitiative AT matendecherosultanihadley evaluatingdengueburdeninafricainpassivefeversurveillanceandseroprevalencestudiesprotocoloffieldstudiesofthedenguevaccineinitiative AT esenmeral evaluatingdengueburdeninafricainpassivefeversurveillanceandseroprevalencestudiesprotocoloffieldstudiesofthedenguevaccineinitiative AT andiaesther evaluatingdengueburdeninafricainpassivefeversurveillanceandseroprevalencestudiesprotocoloffieldstudiesofthedenguevaccineinitiative AT oyembonoah evaluatingdengueburdeninafricainpassivefeversurveillanceandseroprevalencestudiesprotocoloffieldstudiesofthedenguevaccineinitiative AT barroahmed evaluatingdengueburdeninafricainpassivefeversurveillanceandseroprevalencestudiesprotocoloffieldstudiesofthedenguevaccineinitiative AT bonnetemmanuel evaluatingdengueburdeninafricainpassivefeversurveillanceandseroprevalencestudiesprotocoloffieldstudiesofthedenguevaccineinitiative AT njengasammym evaluatingdengueburdeninafricainpassivefeversurveillanceandseroprevalencestudiesprotocoloffieldstudiesofthedenguevaccineinitiative AT agnandjiselidjitodagbe evaluatingdengueburdeninafricainpassivefeversurveillanceandseroprevalencestudiesprotocoloffieldstudiesofthedenguevaccineinitiative AT yaroseydou evaluatingdengueburdeninafricainpassivefeversurveillanceandseroprevalencestudiesprotocoloffieldstudiesofthedenguevaccineinitiative AT alexanderneal evaluatingdengueburdeninafricainpassivefeversurveillanceandseroprevalencestudiesprotocoloffieldstudiesofthedenguevaccineinitiative AT yooninkyu evaluatingdengueburdeninafricainpassivefeversurveillanceandseroprevalencestudiesprotocoloffieldstudiesofthedenguevaccineinitiative |